Champoux Jennifer
Insider CIK 2025233 · GLUE Chief Operating Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GLUE Monte Rosa Therapeutics, I | M Exercise deriv | 2026-07-15 | 2026-07-16 | 4,351 | — | $0 | 26,947 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | M Exercise | 2026-07-15 | 2026-07-16 | 4,351 | $3.98 | $17.3K | 66,722 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | S Sale | 2026-07-15 | 2026-07-16 | 4,351 | $23.38 | $101.7K | 62,371 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | M Exercise deriv | 2026-06-23 | 2026-06-25 | 2,175 | — | $0 | 31,298 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | M Exercise | 2026-06-23 | 2026-06-25 | 2,175 | $3.98 | $8.7K | 64,546 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | S Sale | 2026-06-23 | 2026-06-25 | 2,175 | $20.00 | $43.5K | 62,371 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | M Exercise deriv | 2026-06-17 | 2026-06-18 | 2,176 | — | $0 | 33,473 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | S Sale | 2026-06-17 | 2026-06-18 | 2,176 | $19.00 | $41.3K | 62,371 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | M Exercise | 2026-06-17 | 2026-06-18 | 2,176 | $3.98 | $8.7K | 64,547 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | M Exercise deriv | 2026-05-27 | 2026-05-28 | 2,175 | — | $0 | 35,649 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | M Exercise | 2026-05-27 | 2026-05-28 | 2,175 | $3.98 | $8.7K | 64,546 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | S Sale | 2026-05-27 | 2026-05-28 | 2,175 | $20.00 | $43.5K | 62,371 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | M Exercise deriv | 2026-05-22 | 2026-05-26 | 2,176 | — | $0 | 37,824 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | M Exercise | 2026-05-22 | 2026-05-26 | 2,176 | $3.98 | $8.7K | 64,547 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | S Sale | 2026-05-22 | 2026-05-26 | 2,176 | $19.00 | $41.3K | 62,371 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | S Sale | 2026-01-05 | 2026-01-05 | 2,629 | $15.17 | $39.9K | 62,371 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2026-01-02 | 2026-01-05 | 158,000 | — | $0 | 158,000 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award | 2026-01-02 | 2026-01-05 | 35,000 | — | $0 | 65,000 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2025-01-02 | 2025-01-06 | 135,000 | — | $0 | 135,000 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award | 2025-01-02 | 2025-01-06 | 30,000 | — | $0 | 30,000 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2024-06-03 | 2024-06-05 | 40,000 | — | $0 | 40,000 | SEC↗ |